New drug could ease lupus skin flares in major trial

NCT ID NCT07355218

Recruiting now Disease control Sponsor: EMD Serono Research & Development Institute, Inc. Source: ClinicalTrials.gov ↗

First seen Jan 21, 2026 · Last updated May 23, 2026 · Updated 11 times

Summary

This study tests an experimental drug called enpatoran for people with lupus who have active skin rashes. About 202 participants will receive either enpatoran or a placebo on top of their usual treatments for 24 weeks. The goal is to see if the drug can significantly reduce skin symptoms without causing serious side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS LUPUS ERYTHEMATOSUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bolanos Clinical Research
RECRUITING

Pembroke Pines, Florida, 33026, United States
Dawes Fretzin Clinical Research Group, LLC
RECRUITING

Indianapolis, Indiana, 46250, United States
Inland Rheumatology Clinical Trials, Inc.
RECRUITING

Upland, California, 91786, United States
Omega Research Debary, LLC
RECRUITING

DeBary, Florida, 32713, United States

Conditions

Explore the condition pages connected to this study.

CUTANEOUS LUPUS ERYTHEMATOSUS SYSTEMATIC LUPUS ERYTHEMATOSUS SYSTEMATIC LUPUS ERYTHEMATOSUS